Research Article| Volume 54, ISSUE 2, P227-238, May 1982

Virus antibodies in Parkinson's disease

Herpes simplex and measles virus antibodies in serum and CSF and their relation to HLA types
      This paper is only available as a PDF. To read, Please Download here.


      Serum and cerebrospinal fluid (CSF) immunoglobulin G (IgG) antibodies to herpes simplex (HSV) and measles viruses were assayed with a radioimmunoassay in 56 patients with idiopathic Parkinson's disease and in a similar number of age- and sex-matched controls with other neurological diseases. As a group, the patients with Parkinson's disease had a significantly increased serum antibody level against HSV, but measles virus antibody levels were similar in both groups. Both in the Parkinson's group and in the control group, the levels of the total IgG in CSF were within normal limits and the CSF antibodies to HSV and measles virus paralleled the serum antibody titers relative to the total IgG serum-to-CSF ratios. This indicates no increased intrathecal antibody production in either group. In 48 patients with Parkinson's disease who were HLA-typed, no association of viral antibody levels with particular HLA antigens were noted.
      The findings suggest that HSV is not present within the central nervous system of the patients with Parkinson's disease. The increased HSV antibody level seen in Parkinson's disease patients may reflect a more general disturbance of the patients' immune functions.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Armitage P.
        Statistical Methods in Medical Research.
        in: Blackwell Scientific Publications, Oxford1974: 279-301
        • Arstila P.
        • Vuorimaa T.
        • Kalimo K.
        • Halonen P.
        • Viljanen M.
        • Granfors K.
        • Toivanen P.
        Solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.
        J. gen. Virol. 1977; 34: 167-176
        • Calne D.B.
        • Eisler T.
        The pathogenesis and medical treatment of extrapyramidal disease.
        Med. Clin. North Amer. 1979; 63: 715-727
        • Dawidovitz S.
        • Zamir R.
        • Kott E.
        HLA antigens in Parkinson's disease.
        in: Den Hartog Jager W.A. Bruyn G.W. Heijstee A.P.J. 11th World Congress of Neurology. Excerpta Medica, Amsterdam1977: 126
        • Desforges J.F.
        • Hollenberg N.K.
        • Ingelfinger F.J.
        • Malt R.A.
        • Smith A.L.
        What does a healthy control control?.
        N. Engl. J. Med. 1977; 269: 1165-1166
        • Elizan T.S.
        • Schwartz J.
        • Yahr M.D.
        • Casals J.
        Antibodies against arboviruses in postencephalitic and idiopathic Parkinson's disease.
        Arch. Neurol. (Chic.). 1978; 35: 257-260
        • Elizan T.S.
        • Madden D.L.
        • Noble G.R.
        • Herrmann K.L.
        • Gardner J.
        • Schwartz J.
        • Smith H.
        • Sever J.L.
        • Yahr M.D.
        Viral antibodies in serum and CSF of parkinsonian patients and controls.
        Arch. Neurol. (Chic.). 1979; 36: 529-534
        • Elizan T.S.
        • Terasaki P.I.
        • Yahr M.D.
        HLA-B14 antigen and postencephalitic Parkinson's disease — Their association in an American-Jewish ethnic group.
        Arch. Neurol. (Chic.). 1980; 37: 542-544
        • Emile J.
        • Tuelle J.L.
        • Pouplard A.
        • Hurez D.
        Association maladie de Parkinson-antigènes HLA-B17 et B18.
        Nouv. Presse méd. 1977; 6: 6144
        • Emile J.
        • Pouplard A
        • van Nieuwenhuyse C.Bossu
        • Bernat-Viallet Ch.
        Maladie de Parkinson, dysautonomie et auto-anticorps dirigés contre les neurones sympathiques.
        Rev. neurol. 1980; 136: 221-233
        • Hoehn M.M.
        • Yahr M.D.
        Parkinsonism: onset, progression, and mortality.
        Neurology (Minneap.). 1967; 17: 427-442
        • Husby G.
        • Li L.
        • Davis L.
        • Wedege E.
        • Kokmen E.
        • Williams Jr., R.C.
        Antibodies to human caudate nucleus neurons in Huntington's chorea.
        J. clin. Invest. 1977; 59: 922-932
        • Husby G.
        • Williams Jr., R.C.
        • Bersin R.M.
        • Lewis M.K.
        Antineuronal antibodies in diseases affecting the basal ganglia particularly Sydenham's and Huntington's chorea.
        in: Rose F.C. Clinical Neuroimmunology. Blackwell Scientific Publications, Oxford1979: 90-105
        • Ilonen J.
        • Reunanen M.
        • Salmi A.
        • Tiilikainen A.
        Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
        J. neurol. Sci. 1981; 49: 117-133
        • Kalimo K.O.K.
        • Marttila R.J.
        • Granfors K.
        • Viljanen M.K.
        Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.
        Infect. Immun. 1977; 15: 883-889
        • Kalimo K.O.K.
        • Marttila R.J.
        • Ziola B.R.
        • Matikainen M.T.
        • Panelius M.
        Radio-immunoassay of herpes-simplex and measles virus antibodies in serum and cerebrospinal fluid of patients without infections or demyelinating diseases of the central nervous system.
        J. med. Microbiol. 1977; 10: 431-438
        • Kibrick S.
        • Gooding G.W.
        Pathogenesis of infection with herpes simplex virus with special reference to nervous tissue.
        NINDB Monograph No. 2. 1965; (Bethesda, MD): 143-154
        • Lehrich J.R.
        • Arnason B.G.W.
        Histocompatibility types and viral antibodies.
        Arch. Neurol. (Chic.). 1976; 33: 404-405
        • MacCallum F.O.
        • Chinn I.J.
        • Gostling J.V.T.
        Antibodies to herpes-simplex virus in the cerebrospinal fluid of patients with herpetic encephalitis.
        J. med. Microbiol. 1973; 7: 325-331
        • McDewitt H.O.
        Regulation of the immune response by the major histocompatibility system.
        N. Engl. J. Med. 1980; 303: 1514-1517
        • Madden D.L.
        • Wallen W.C.
        • Sever J.L.
        Cellular immunology in multiple sclerosis — Response to several viruses.
        in: Karchner D. Lowenthal A. Strosberg A.D. Humoral Immunity in Neurological Diseases. Plenum Press Inc, New York, NY1979: 17-35
        • Mancini G.
        • Carbonara A.O.
        • Heremans J.F.
        Immunochemical quantitation of antigens by single radial immunodiffusion.
        Immunochemistry. 1965; 2: 235-254
        • Marttila R.J.
        Etiology of Parkinson's disease.
        in: Rinne U.K. Klingler M. Stamm G. Parkinson's Disease — Current Progress, Problems and Management. Elsevier/North-Holland, Amsterdam1980: 3-15
        • Marttila R.J.
        • Arstila P.
        • Nikoskelainen J.
        • Halonen P.
        • Rinne U.K.
        Viral antibodies in the sera from patients with Parkinson disease.
        Europ. Neurol. 1977; 15: 25-33
        • Marttila R.J.
        • Kalimo K.O.K.
        • Ziola B.R.
        • Halonen P.E.
        • Rinne U.K.
        Herpes simplex virus subunit antibodies in patients with Parkinson's disease.
        Arch. Neurol. (Chic.). 1978; 35: 668-671
        • Marttila R.J.
        • Rinne U.K.
        • Halonen P.
        • Madden D.L.
        • Sever J.L.
        Herpesviruses and Parkinsonism: herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF.
        Arch. Neurol. (Chic.). 1981; 38: 19-21
        • Marttila R.J.
        • Rinne U.K.
        • Tiilikainen A.
        Histocompatibility types in Parkinson's disease.
        J. neurol. Sci. 1981; 51: 217-221
        • Nahmias A.J.
        • Roizman B.
        Infection with herpes-simplex viruses 1 and 2 (second of three parts).
        N. Engl. J. Med. 1973; 289: 719-725
        • Pouplard A.
        • Emile J.
        • Pouplard F.
        • Hurez D.
        Parkinsonism and autoimmunity — Antibody against human sympathetic ganglion cells in Parkinson's disease.
        Adv. Neurol. 1979; 24: 321-326
        • Schwartz J.
        • Elizan T.S.
        Search for viral particles and virus-specific products in idiopathic Parkinson disease brain material.
        Ann. Neurol. 1979; 6: 261-263
        • Sköldenberg B.
        • Kalimo K.
        • Carlström A.
        • Forsgren M.
        • Halonen P.
        Herpes simplex encephalitis — A serological follow-up study.
        Acta neurol. scand. 1981; 63: 273-285
        • Stewart G.J.
        • Basten A.
        • Guinan J.
        • Bashir H.V.
        • Cameron J.
        • McLeod J.G.
        HLA-Dw2, viral immunity and family studies in multiple sclerosis.
        J. neurol. Sci. 1977; 32: 153-167
        • Visscher B.
        • Myers L.W.
        • Ellison G.W.
        • Malmgren R.M.
        • Detels R.
        • Lucia M.V.
        • Madden D.L.
        • Sever J.L.
        • Park M.S.
        • Coulson A.H.
        HLA types and immunity in multiple sclerosis.
        Neurology (Minneap.). 1979; 29: 1561-1565
        • Wetmur J.G.
        • Schwartz J.
        • Elizan T.S.
        Nucleic acid homology studies of viral nucleic acids in idiopathic Parkinson's disease.
        Arch. Neurol. (Chic.). 1979; 36: 462-464